Samedan Ltd Pharmaceutical Publishers

Advanced search

Publications

European Pharmaceutical
Contractor

European Biopharmaceutical
Review

International Clinical Trials

Pharmaceutical Manufacturing
and Packing Sourcer

Innovations in Pharmaceutical
Technology

Subscribe Online

Conferences

White Papers

Samedan app

Pharmaceutical Directory

Industry Events Calendar

News and Press Releases

Employment Opportunities

Advertising with us

Air Transport Publications

home > pmps > Autumn 2008

PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

Autumn 2008

At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.

Text

PDF

Manufacturing

Brian Dougherty of SCM Pharma Ltd suggests that it is time to seek out new ways to capitalise on innovation in the clinical manufacturing sector

Felix Nink at Bosch argues that automation and modular design are radically changing how pharmaceutical processing looks at containment

Benoоt Verjans of Aseptic Tech introduces closed vial technology: a new methodology for aseptic filling of injectable drugs

Kevin Menard at PerkinElmer Life and Analytical Sciences cites hyphenated techniques as the next generation in laboratory advancements for the pharmaceutical industry

Getting a potential new drug or product from the research and development stage into use has to be the key commercial consideration for pharmaceutical companies. Mark Perry from Siemens Automation and Drives explains how embracing manufacturing execution systems (MES) can have a real impact in an industry when every day counts towards financial success

Drug Delivery

Dr Renaud Janssen at Helvoet Pharma examines the use of silicon in the manufacture of pre-filled syringes, and details its importance in the production of a safe, high-quality product

François Dessus and Flore Demay at Stelmi discuss how to ensure the highest degree of assurance in the production of rubber stoppers sterilised by gamma irradiation

Cedric Marmonier at Rovipharm traces the development of liquid drug administration from the spoon to the syringe, and examines possible future development

Paul Kippax of Malvern Instruments and David Morton of Monash University assess the benefits of using dry powder inhalers in order to optimise the delivery of a wide range of medicinal drugs

Ed Wynn at ANSYS analyses the impact of computational fluid dynamics on pulmonary drug delivery

Formulations, Ingredients and Excipients

Kevin Maynard at Imprint Pharmaceuticals and Victor Breedveld from the Georgia Institute of Technology discuss particle tracking microrheology

Partnerships between pharma and excipient manufacturers can extend drug patents through novel functionalities and formulations; Hans Huttinga at Sheffield Pharma Ingredients investigates

IT and Logistics

Leigh Jordan at Cognex UK Ltd identifies machine vision and coding as essential ingredients of an efficient traceability strategy

Chris Stumpf and Phil Kilby at Waters discuss lean process improvements for the GMP laboratory

PACKING, PACKAGING & ANTI-COUNTERFEITING

Benjamin Kepp of Bischof + Klein GmbH discusses how flexible packaging can solve contamination problems across the whole drug development process

John Gill at the Royal National Institute for the Blind discusses what can be done by pharmaceutical packagers to help blind and partially sighted people

Gerhard Breu at Körber Medipak explains how the bar in patient compliance can be raised through box wallet packaging

With pharmaceutical labelling becoming increasingly regulated, manufacturers and packaging companies are looking for a simple and cost-effective solution. Mark Beauchamp at Citizen Systems Europe explains that the latest generation of label printing technology can meet both requirements

Paul Stiff at Farnham Castle International Briefing Centre examines the inherent difficulties in recognising international commercial needs in packaging and manufacturing

COOL CHAIN

Geraint Thomas at Laminar Medica explains how the latest temperature-controlled packaging technology is helping pharmaceutical companies meet the growing challenge of shipping temperature-sensitive products

Chris Fore at Envirotainer presents strategies to meet transport service provider obligations as defined in Parental Drug Association Technical Report Number 39

In the current financial climate, making the correct choice when selecting chillers and air conditioning systems is more important than ever; Steve Warnock of the Coolmation Group explains why the sector should consider Turbocor compressor chillers when reviewing climate control

Tony Wright at Exelsius Cold Chain Management Consultancy examines cold chain management, and tells us it is key to securing both patient safety and the quality of pharmaceutical products

Tim Jennings of Emball’iso SA talks to PMPS about the expanding cold chain sector of the pharmaceutical industry

Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August, and November

News and Press Releases

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.
More info >>

All releases >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

All white papers >>

Industry Events

Highly Potent Active Pharmaceutical Ingredients (HPAPI)

13-14 May 2019, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019. The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.
More info >>

All events >>